Skip to main content
Top
Published in: Head and Neck Pathology 3/2013

01-09-2013 | Case Report

Reactive Tonsillar Enlargement Showing Strong 18F-Fdg Uptake During the Follow-Up of Follicular Lymphoma

Authors: Patricia do Socorro Queiroz Feio, Camilla Borges Ferreira Gomes, Alexandre Simões Nogueira, Luciana Yamamoto Almeida, José Vassallo, Fernando Augusto Soares, Oslei Paes Almeida, Jorge Esquiche León

Published in: Head and Neck Pathology | Issue 3/2013

Login to get access

Abstract

The 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has become a standard procedure for the diagnosis, staging, and restaging in lymphoma patients. However, a relative high rate of false-positive results has been reported. We report a case of a 40-year-old man with a previous history of a nodal follicular lymphoma, stage IVA, treated with R-CHOP, which showed strong 18F-FDG uptake in the Waldeyer’s tonsillar ring during his follow-up, being considered highly suspicious of relapsed lymphoma. A surgical removal of the palatine tonsils and adenoids was performed, which showed reactive follicular hyperplasia. Furthermore, bone marrow biopsy revealed absence of neoplasia. The patient is still in follow-up with no signs of recurrent lymphoma. This case illustrates that, despite the high sensitivity for the detection of recurrent lymphoma, 18F-FDG uptake should be interpreted with great caution and confirmatory studies should be performed before any therapy.
Literature
1.
go back to reference Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94:429–33.PubMed Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94:429–33.PubMed
2.
go back to reference Beker DB, Berrak SG, Canpolat C, et al. False positivity of FDG-PET/CT in a child with Hodgkin disease. Pediatr Blood Cancer. 2008;50:881–3.PubMedCrossRef Beker DB, Berrak SG, Canpolat C, et al. False positivity of FDG-PET/CT in a child with Hodgkin disease. Pediatr Blood Cancer. 2008;50:881–3.PubMedCrossRef
3.
go back to reference Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging. 2011;2:679–98.PubMedCrossRef Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging. 2011;2:679–98.PubMedCrossRef
4.
go back to reference Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234:879–85.PubMedCrossRef Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234:879–85.PubMedCrossRef
5.
go back to reference Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake–the role of PET/CT. Eur Radiol. 2006;16:1054–65.PubMedCrossRef Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake–the role of PET/CT. Eur Radiol. 2006;16:1054–65.PubMedCrossRef
6.
go back to reference Bhargava P, Parker JA, Dezube BJ. Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F] fluorodeoxyglucose positron emission tomography. Clin Lymphoma Myeloma. 2008;8:117–20.PubMedCrossRef Bhargava P, Parker JA, Dezube BJ. Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F] fluorodeoxyglucose positron emission tomography. Clin Lymphoma Myeloma. 2008;8:117–20.PubMedCrossRef
7.
go back to reference Crocchiolo R, Fallanca F, Giovacchini G, et al. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma. Ann Hematol. 2009;88:1229–36.PubMedCrossRef Crocchiolo R, Fallanca F, Giovacchini G, et al. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma. Ann Hematol. 2009;88:1229–36.PubMedCrossRef
8.
go back to reference Hosokai R, Imai C, Takachi T, et al. Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma. J Pediatr Hematol Oncol. 2011;33:e87–8.PubMedCrossRef Hosokai R, Imai C, Takachi T, et al. Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma. J Pediatr Hematol Oncol. 2011;33:e87–8.PubMedCrossRef
9.
go back to reference Ioachim HL, Medeiros LJ. Reactive Lymphoid Hyperplasia. In: Ioachim HL, Medeiros LJ, editors. Lymph Node Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 172–80. Ioachim HL, Medeiros LJ. Reactive Lymphoid Hyperplasia. In: Ioachim HL, Medeiros LJ, editors. Lymph Node Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 172–80.
10.
go back to reference Hasserjian RP, Chen S, Perkins SL, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532–40.PubMedCrossRef Hasserjian RP, Chen S, Perkins SL, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532–40.PubMedCrossRef
11.
go back to reference Tokuc G, Oktem S, Genc A. Nasopharyngeal lymphoid hyperplasia after therapy for childhood lymphomas. Acta Oncol. 2006;45:618–20.PubMedCrossRef Tokuc G, Oktem S, Genc A. Nasopharyngeal lymphoid hyperplasia after therapy for childhood lymphomas. Acta Oncol. 2006;45:618–20.PubMedCrossRef
12.
go back to reference Kojima M, Murayama K, Higuchi K, et al. Reactive lymphoid hyperplasia with giant follicles associated with post-therapeutic state of hematological malignancies: a report of six cases. Leuk Lymphoma. 2006;47:1404–6.PubMedCrossRef Kojima M, Murayama K, Higuchi K, et al. Reactive lymphoid hyperplasia with giant follicles associated with post-therapeutic state of hematological malignancies: a report of six cases. Leuk Lymphoma. 2006;47:1404–6.PubMedCrossRef
13.
go back to reference Chen YK, Su CT, Chi KH, et al. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer’s ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med. 2007;48:8–14.PubMed Chen YK, Su CT, Chi KH, et al. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer’s ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med. 2007;48:8–14.PubMed
14.
go back to reference Metser U, Even-Sapir E. Increased (18) F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007;37:206–22.PubMedCrossRef Metser U, Even-Sapir E. Increased (18) F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007;37:206–22.PubMedCrossRef
15.
go back to reference Makis W, Ciarallo A, Lisbona R. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT. Acta Radiol. 2011;52:970–2.PubMedCrossRef Makis W, Ciarallo A, Lisbona R. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT. Acta Radiol. 2011;52:970–2.PubMedCrossRef
16.
go back to reference Kalkanis D, Kalkani M, Gomes H, et al. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate. Clin Nucl Med. 2010;35:24–5.PubMedCrossRef Kalkanis D, Kalkani M, Gomes H, et al. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate. Clin Nucl Med. 2010;35:24–5.PubMedCrossRef
17.
go back to reference Kyo C, Kawaoka Y, Kinoshita K, et al. Mantle cell lymphoma presenting with a tumor of the hard palate. Intern Med. 2010;49:1663–6.PubMedCrossRef Kyo C, Kawaoka Y, Kinoshita K, et al. Mantle cell lymphoma presenting with a tumor of the hard palate. Intern Med. 2010;49:1663–6.PubMedCrossRef
18.
go back to reference Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic and artifactual FDG uptake. Radiographics. 2005;25:897–912.PubMedCrossRef Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic and artifactual FDG uptake. Radiographics. 2005;25:897–912.PubMedCrossRef
19.
go back to reference Wong WL, Gibson D, Sanghera B, et al. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study. Nucl Med Commun. 2007;28:675–80.PubMedCrossRef Wong WL, Gibson D, Sanghera B, et al. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study. Nucl Med Commun. 2007;28:675–80.PubMedCrossRef
20.
go back to reference Chung JH, Cho KJ, Lee SS, et al. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18) F-FDG PET results in lung cancer staging. J Nucl Med. 2004;45:999–1003.PubMed Chung JH, Cho KJ, Lee SS, et al. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18) F-FDG PET results in lung cancer staging. J Nucl Med. 2004;45:999–1003.PubMed
21.
go back to reference Nakagawa T, Yamada M, Suzuki Y. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med. 2008;49:1053–9.PubMedCrossRef Nakagawa T, Yamada M, Suzuki Y. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med. 2008;49:1053–9.PubMedCrossRef
22.
go back to reference Oguz A, Karadeniz C, Citak EC, et al. Thymic and adenotonsillar enlargement after successful treatment of malignancies. Pediatr Hematol Oncol. 2005;22:423–35.PubMedCrossRef Oguz A, Karadeniz C, Citak EC, et al. Thymic and adenotonsillar enlargement after successful treatment of malignancies. Pediatr Hematol Oncol. 2005;22:423–35.PubMedCrossRef
23.
go back to reference Wöhrer S, Jaeger U, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol. 2006;17:780–4.PubMedCrossRef Wöhrer S, Jaeger U, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol. 2006;17:780–4.PubMedCrossRef
24.
go back to reference Good DJ, Gascoyne RD. Atypical lymphoid hyperplasia mimicking lymphoma. Hematol Oncol Clin North Am. 2009;23:729–45.PubMedCrossRef Good DJ, Gascoyne RD. Atypical lymphoid hyperplasia mimicking lymphoma. Hematol Oncol Clin North Am. 2009;23:729–45.PubMedCrossRef
Metadata
Title
Reactive Tonsillar Enlargement Showing Strong 18F-Fdg Uptake During the Follow-Up of Follicular Lymphoma
Authors
Patricia do Socorro Queiroz Feio
Camilla Borges Ferreira Gomes
Alexandre Simões Nogueira
Luciana Yamamoto Almeida
José Vassallo
Fernando Augusto Soares
Oslei Paes Almeida
Jorge Esquiche León
Publication date
01-09-2013
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 3/2013
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-012-0400-5

Other articles of this Issue 3/2013

Head and Neck Pathology 3/2013 Go to the issue